TY - JOUR
T1 - Characteristics of TAV- and BAV-associated thoracic aortic aneurysms--smooth muscle cell biology, expression profiling, and histological analyses
AU - Blunder, Stefan
AU - Messner, Barbara
AU - Aschacher, Thomas
AU - Zeller, Iris
AU - Türkcan, Adrian
AU - Wiedemann, Dominik
AU - Andreas, Martin
AU - Blüschke, Gert
AU - Laufer, Günther
AU - Schachner, Thomas
AU - Bernhard, David
N1 - Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
PY - 2012/2
Y1 - 2012/2
N2 - OBJECTIVE: Past studies on the pathogenesis of thoracic aortic aneurysms have, by concentrating on histological and total tissue analyses, revealed several disease-relevant processes. Despite these studies, there is still a significant lack in the understanding of aneurysmal cell biology today. Hence, it was the goal of this study to assess differences between aneurysmal and healthy aortic smooth muscle cells (SMCs) on a broad - screening-like - basis, allowing us to formulate new hypotheses on the role of SMCs in thoracic aneurysm formation.METHODS AND RESULTS: After histological characterization of a total of 16 samples from healthy aortas and thoracic aortic aneurysms (TAA) of patients with bicuspid (BAV) and tricuspid (TAV) aortic valves, we isolated aortic SMCs and subjected them to cell biological and gene expression analyses. The data obtained indicate that aneurysmal SMCs exert reduced proliferation and migration rates compared to controls. BAV TAA SMCs have significantly shorter telomeres, whereas TAV TAA SMCs showed a reduced metabolic activity. In BAV TAA SMCs osteopontin (OPN) expression was significantly elevated, and TAV TAA SMCs showed decreased expression of tissue inhibitor of metalloproteinase 3 (TIMP3).CONCLUSION: Our study provides evidence that TAA-associated aortic wall disintegration in BAV and TAV TAAs shows similarities, but also significant differences. BAV and TAV TAAs differ with regard to medial elastic fiber mass and the occurrence of fibroblasts, SMC telomere length, metabolism, and gene expression. This study may form the basis for future in-depth analyses on the relevance of these findings in the pathophysiology of BAV and TAV TAAs.
AB - OBJECTIVE: Past studies on the pathogenesis of thoracic aortic aneurysms have, by concentrating on histological and total tissue analyses, revealed several disease-relevant processes. Despite these studies, there is still a significant lack in the understanding of aneurysmal cell biology today. Hence, it was the goal of this study to assess differences between aneurysmal and healthy aortic smooth muscle cells (SMCs) on a broad - screening-like - basis, allowing us to formulate new hypotheses on the role of SMCs in thoracic aneurysm formation.METHODS AND RESULTS: After histological characterization of a total of 16 samples from healthy aortas and thoracic aortic aneurysms (TAA) of patients with bicuspid (BAV) and tricuspid (TAV) aortic valves, we isolated aortic SMCs and subjected them to cell biological and gene expression analyses. The data obtained indicate that aneurysmal SMCs exert reduced proliferation and migration rates compared to controls. BAV TAA SMCs have significantly shorter telomeres, whereas TAV TAA SMCs showed a reduced metabolic activity. In BAV TAA SMCs osteopontin (OPN) expression was significantly elevated, and TAV TAA SMCs showed decreased expression of tissue inhibitor of metalloproteinase 3 (TIMP3).CONCLUSION: Our study provides evidence that TAA-associated aortic wall disintegration in BAV and TAV TAAs shows similarities, but also significant differences. BAV and TAV TAAs differ with regard to medial elastic fiber mass and the occurrence of fibroblasts, SMC telomere length, metabolism, and gene expression. This study may form the basis for future in-depth analyses on the relevance of these findings in the pathophysiology of BAV and TAV TAAs.
KW - Adult
KW - Aged
KW - Aorta, Thoracic/metabolism
KW - Aortic Aneurysm, Thoracic/etiology
KW - Aortic Valve/abnormalities
KW - Austria
KW - Blotting, Western
KW - Case-Control Studies
KW - Cell Movement
KW - Cell Proliferation
KW - Cells, Cultured
KW - Elastic Tissue/pathology
KW - Fibroblasts/pathology
KW - Gene Expression Profiling/methods
KW - Gene Expression Regulation
KW - Heart Defects, Congenital/complications
KW - Humans
KW - Immunohistochemistry
KW - Middle Aged
KW - Muscle, Smooth, Vascular/metabolism
KW - Myocytes, Smooth Muscle/metabolism
KW - Osteopontin/genetics
KW - RNA, Messenger/metabolism
KW - Real-Time Polymerase Chain Reaction
KW - Telomere Shortening
KW - Time Factors
KW - Tissue Inhibitor of Metalloproteinase-3/genetics
UR - https://www.scopus.com/pages/publications/84855926435
U2 - 10.1016/j.atherosclerosis.2011.11.035
DO - 10.1016/j.atherosclerosis.2011.11.035
M3 - Journal article
C2 - 22178424
SN - 0021-9150
VL - 220
SP - 355
EP - 361
JO - Atherosclerosis
JF - Atherosclerosis
IS - 2
ER -